tomeko

Autosomal recessive spinocerebellar ataxia 20

Just diagnosed with Autosomal recessive spinocerebellar ataxia 20?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Autosomal recessive spinocerebellar ataxia 20, look for clinical trials, and connect with others living with it — all in one place.

Open the full Autosomal recessive spinocerebellar ataxia 20 hub →

Overview

Autosomal recessive spinocerebellar ataxia 20 is a rare condition. Also known as SNX14-related autosomal recessive spinocerebellar ataxia, Autosomal recessive spinocerebellar ataxia type 20, Intellectual disability-coarse face-macrocephaly-cerebellar hypoplasia syndrome, SCAR20. Tomeko brings together the specialists, research, clinical trials, treatments and community for Autosomal recessive spinocerebellar ataxia 20 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:397709 · OMIM 616354 · ICD-10 Q87.8 · GARD 0017636

Find care for Autosomal recessive spinocerebellar ataxia 20

Authoritative references for Autosomal recessive spinocerebellar ataxia 20

Common questions

I was just diagnosed with Autosomal recessive spinocerebellar ataxia 20 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Autosomal recessive spinocerebellar ataxia 20, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Autosomal recessive spinocerebellar ataxia 20?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Autosomal recessive spinocerebellar ataxia 20, filtered to your area.

Are there clinical trials for Autosomal recessive spinocerebellar ataxia 20?

Tomeko shows live, recruiting studies for Autosomal recessive spinocerebellar ataxia 20 from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com